Cyrex Lab Panels

Measures intestinal permeability to large molecules and identifies the damaging route through the intestinal barrier. 

Recommended for Patients Who:

• Present multiple symptom complaints (including Chronic Fatigue Syndrome)

• Suffer from abnormal immune cell count and function (including autoimmune diseases)

• Complain of food sensitivity and intolerance

Assists in the identification of wheat reactivity, non-celiac gluten sensitivity, Celiac disease, intestinal barrier damage, and wheat-related autoimmunity.

Recommended for Patients Who:

• Have non-responsive GI symptoms

• Present multiple-symptom complaints (including Chronic Fatigue Syndrome and Fibromyalgia)

• Suffer from depression or neuro-autoimmunity

Identifies reactivity to foods known to cross-react to gliadin and reactivity to newly introduced foods on a gluten-free diet.

Recommended for Patients Who:

• Have Non-Celiac Gluten Sensitivity or Celiac disease

• Are experiencing limited improvements or are non-responsive on a gluten-free diet

• Have gut dysbiosis, which appears to be resistant to standard therapy

Measures predictive autoantibodies to assess possible tissue damage to multiple organs of the body. 

Recommended for Patients Who:

• A diagnosed autoimmune disorder, as they commonly develop additional autoimmune conditions

• Chronic increased intestinal permeability, which is the gateway for environmentally-induced autoimmune disorders

Builds upon the Array 7 by adding IgM antibody measurements. It assists in the early detection of neuro-autoimmunity, evaluates the severity of the autoimmune response, and assists in monitoring the effectiveness of related treatment protocols.

Recommended for Patients Who:

• Have idiopathic neurological conditions such as Cerebellar ataxia or Peripheral Neuropathy

• Have Gluten-Reactivity, Dairy Sensitivity and/or enhanced permeability of the Gut and/or Blood-Brain Barrier

Evaluates immune reactions to 180 raw and/or modified foods, food enzymes, lectins, and artificial food additives, including meat glue, colorings and gums. It can detect dietary-related triggers of autoimmune reactivity and monitor the efficacy of customized dietary protocols.

Recommended for Patients Who:

• Seek a life-long health and wellness strategy

• Present with unexplained symptoms whether gastrointestinal, neurological, dermatological or behavioral in nature

• Are suspected of having increased intestinal permeability, which is the gateway for environmentally-induced autoimmune disorders

Measures immune response to chemicals bound to human proteins, unlike other tests that only identify chemical exposure. This measurement helps determine a person’s health risk from chemical exposure. 

Recommended for Patients Who:

• Increased chemical sensitivity/intolerance

• Loss of immune tolerance and/or abnormal immune function 

• Autoimmune disease and/or a family history of autoimmune disease

Detects immune reaction to key pathogens that may lead to multiple autoimmune reactivities. It can also be used to monitor the effectiveness of protocols for addressing autoimmune related pathogens.

Recommended for Patients Who:

• Present with chronic conditions such as gastrointestinal distress, fatigue, body aches or unexplained and general inflammation, including neuroinflammation

• May have been exposed to bacteria, viruses, parasites, molds, and spirochete associated with multiple autoimmunities

• Have not fully responded to clinical interventions, such as detoxification and dietary modifications

Evaluates the possible outcomes of compromised immune tolerance, including intestinal barrier dysfunction, food and chemical immune reactivity, and autoimmunity.

Recommended for Patients Who:

• Have chronic inflammatory bowel conditions

• Have a family history of autoimmune disease

Measures blood-brain barrier permeability and evaluates breaches of the blood-brain barrier by stress, trauma or environmental triggers. It can help investigate contact sports-related traumatic brain injuries, as well as assess risk for developing neurodegenerative disorders.

Recommended for Patients Who:

• Play contact sports during which repeated head trauma occurs

• Engage in activity that involves force or shock to the body and/or head

• Have intestinal permeability with abnormal elevation inLPS and/or Occludin/Zonulin antibodies

• Exhibit changes in cognitive function

Identifies the overgrowth of large intestinal bacteria in the small intestine, as well as evaluates the release of bacterial cytotoxic and their breach of the intestinal barrier. 

Recommended for Patients Who:

• Have irritable bowels

• Exhibit symptoms of malabsorption, including weight loss, enemies or fatty stools

• Have associated conditions such as fatigue, reflux, skin disorders, obesity or food intolerances

It helps identify patients at a greater risk of developing Alzheimer’s disease or other neurological disorders, identify the early stage of neurodegenerative process, and monitor the effectiveness of lifestyle modifications for Alzheimer’s disease.

Recommended for Patients Who:

• Are interested in preventing the development of Alzheimer’s disease or other neurological disorder

• Are exhibiting early signs of Alzheimer’s disease or other neurological disorder

• Have been diagnosed with Alzheimer’s disease

• Have a history of gastrointestinal disorders and/or diabetes

• Played high-impact sports

• Are immunoreactive against specific pathogens, chemicals and foods

Is an innovative new test that establishes a new standard in screening the immune system. It measures the integrity of the immune system based on 29 key biomarkers and determinants.